Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.
about
Chronic Myeloid Leukaemia: A paradigm for malignancy or just a strange disease?Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.Nilotinib for the Frontline Treatment of Chronic Myeloid Leukemia Carrying the p230 Transcript: Dream or Reality?Chronic myeloid leukaemia with extreme thrombocytosis.
P2860
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@ast
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@en
type
label
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@ast
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@en
prefLabel
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@ast
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@en
P2093
P2860
P356
P1476
Chronic Myeloid Leukemia with ...... Role of Molecular Monitoring.
@en
P2093
Janusz Krawczyk
Johanna Kelly
Kanthi Perera
Philip T Murphy
Sarah L McCarron
Stephen E Langabeer
Suzanne McPherson
P2860
P304
P356
10.1155/2012/458716
P577
2012-07-02T00:00:00Z